Sarah Burke, the Mexico City Bureau Chief for The Economist, shares insights on the alarming trend of Mexican drug cartels diversifying their activities beyond drug trafficking into sectors like mining. With a focus on local economic impacts, she highlights the complex nature of cartel operations and the violence they inflict on communities. Meanwhile, Gilad Amit, a Science correspondent, delves into the promise of bacteriophages as a groundbreaking alternative to combat antibiotic resistance, urging urgent advancements in this field.